FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Warren Heston

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Mouse
Rats

Concepts & Ideas

Molecular Sequence Data

Procedures

Physiology

Co-author Network

Publications

TOP 3
Xinning Wang; Zhenghong Lee; Haibin Tian; Warren D W Heston
Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists.
Xinning Wang; Dangshe Ma; William C Olson; Warren D W Heston
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Lihong Yin; Paul Elson; Michael Ittmann; Pravin Rao; Jianghua Wang; Warren D W Heston
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Warren Heston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Xinning Wang; Zhenghong Lee; Haibin Tian; Warren D W Heston
Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists.
Nucleosides, nucleotides & nucleic acids 2012;31(5):432-44.
2011: Xinning Wang; Dangshe Ma; William C Olson; Warren D W Heston
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Molecular cancer therapeutics 2011;10(9):1728-39.
2011: Lihong Yin; Paul Elson; Michael Ittmann; Pravin Rao; Jianghua Wang; Warren D W Heston
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
PloS one 2011;6(6):e21319.
2008: Veronica Yao; Anil Parwani; Christoph Maier; Warren D W Heston; Dean John Bacich
Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.
Cancer research 2008;68(21):9070-7.
2007: Xinning Wang; Lihong Yin; Pravin Rao; Robert Stein; Kelley M Harsch; Zhenghong Lee; Warren D W Heston
Targeted treatment of prostate cancer.
Journal of cellular biochemistry 2007;102(3):571-9.
2007: William C Olson; Warren D W Heston; Ayyappan K Rajasekaran
Clinical trials of cancer therapies targeting prostate-specific membrane antigen.
Reviews on recent clinical trials 2007;2(3):182-90.
2007: Angelo Baccala; Linda Sercia; Jianbo Li; Warren D W Heston; Ming Zhou
Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
Urology 2007;70(2):385-90.
2007: Robert J Durso; Sofija Andjelic; Jason P Gardner; Dennis J Margitich; Gerald P Donovan; Robert R Arrigale; Xinning Wang; Maureen F Maughan; Todd Talarico; Robert A Olmsted; Warren D W Heston; Paul J Maddon; William C Olson
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3999-4008.
2007: Hagen Cramer; James R Okicki; Taikyun Rho; Xinning Wang; Robert H Silverman; Warren D W Heston
2-5A ligands--a new concept for the treatment of prostate cancer.
Nucleosides, nucleotides & nucleic acids 2007;26(10-12):1471-7.
2005: Terence P F Gade; WALEED HASSEN; Elmer B Santos; Gertrude Gunset; Aurore Saudemont; Michael C Gong; Renier J Brentjens; Xiao-Song Zhong; Matthias Stephan; Jolanta Stefanski; Clay Lyddane; Joseph R Osborne; Ian M Buchanan; Simon J Hall; Warren D W Heston; Isabelle Riviere; Steven M Larson; Jason A Koutcher; Michel Sadelain
Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
Cancer research 2005;65(19):9080-8.
2005: Dean J Bacich; Krystyna M Wozniak; X-C May Lu; Denise S O'Keefe; Noëlle Callizot; Warren D W Heston; Barbara Slusher
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury.
Journal of neurochemistry 2005;95(2):314-23.
2005: Minoru Horinaga; Ryuichi Fukuyama; Toru Nishiyama; Kelley M Harsch; Muzaffer Cicek; Warren D W Heston; Nywana Sizemore; Graham Casey; William Larchian
Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cells.
Urology 2005;66(3):676-81.
2005: Polly D Gregor; Jedd D Wolchok; Vandana Turaga; Jean-Baptiste Latouche; Michel Sadelain; Dean J Bacich; Warren D W Heston; Alan N Houghton; Howard I Scher
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
International journal of cancer. Journal international du cancer 2005;116(3):415-21.
2005: Minoru Horinaga; Kelley M Harsch; Ryuichi Fukuyama; Warren D W Heston; William Larchian
Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.
Urology 2005;66(2):461-6.
2005: Arundhati Ghosh; Xinning Wang; Eric Klein; Warren D W Heston
Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.
Cancer research 2005;65(3):727-31.
2004: Denise S O'Keefe; Warren D W Heston
Clearing up the confusion over the glutamate carboxypeptidase II gene.
American journal of medical genetics. Part A 2004;130A(3):327; author reply 329-30.
2004: Polly D Gregor; Jedd D Wolchok; Cristina R Ferrone; Heidi Buchinshky; Jose A. Guevara-Patino; Miguel-Angel Perales; Fariborz Mortazavi; Dean J Bacich; Warren D W Heston; Jean-Baptiste Latouche; Michel Sadelain; James P Allison; Howard I Scher; Alan N Houghton
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Vaccine 2004;22(13-14):1700-8.
2004: Arundhati Ghosh; Warren D W Heston
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Journal of cellular biochemistry 2004;91(3):528-39.
2004: Denise S O'Keefe; Dean J Bacich; Warren D W Heston
Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
The Prostate 2004;58(2):200-10.
2003: Sigrid A Rajasekaran; Gopalakrishnapillai Anilkumar; Eri Oshima; James U Bowie; He Liu; Warren D W Heston; Neil H Bander; Ayyappan K Rajasekaran
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.
Molecular biology of the cell 2003;14(12):4835-45.
2003: Norbert Schülke; Olga A Varlamova; Gerald P Donovan; Dangshe Ma; Jason P Gardner; Donna M Morrissey; Robert R Arrigale; Cenchen Zhan; Amy J Chodera; Kenneth G Surowitz; Paul J Maddon; Warren D W Heston; William C Olson
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12590-5.
2003: Sarmishtha De; Juhua Chen; Natalya V Narizhneva; Warren D W Heston; Jennifer Brainard; E Helene Sage; Tatiana V Byzova
Molecular pathway for cancer metastasis to bone.
The Journal of biological chemistry 2003;278(40):39044-50.
2003: Arundhati Ghosh; Warren D W Heston
Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen.
The Prostate 2003;57(2):140-51.
2002: Dean J Bacich; Epolia Ramadan; Denise S O'Keefe; Noreen Bukhari; Iga N Wegorzewska; Olumide Ojeifo; Rafal T Olszewski; Craige C Wrenn; Tomasz Bzdega; Barbara Wroblewska; Warren D W Heston; Joseph H Neale
Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Journal of neurochemistry 2002;83(1):20-9.
2002: Paul J Cozzi; Peter B Burke; Amit Bhargav; Warren D W Heston; Bob Huryk; Peter T Scardino; Yuman Fong
Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.
The Prostate 2002;53(2):95-100.
2002: John Thomas; Manjula Gupta; Ying Grasso; Chandana A Reddy; Warren D W Heston; Craig D Zippe; Robert Dreicer; Patrick A Kupelian; Jennifer Brainard; Howard S Levin; Eric A Klein
Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3213-8.
2002: Sam S Chang; Warren D W Heston
The clinical role of prostate-specific membrane antigen (PSMA).
Urologic oncology 2002;7(1):7-12.
2001: A Uchida; Denise S O'Keefe; Dean J Bacich; Peter Molloy; Warren D W Heston
In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Urology 2001;58(2 Suppl 1):132-9.
2001: Peter R Carroll; William R Fair; Gary D Grossfeld; Warren D W Heston; R Lieberman; S B Malkowicz; H J Stricker; J Sylvester; D M Peehl; F Meyer; C Hart
Overview consensus statement.
Urology 2001;58(2 Suppl 1):1-4.
2001: Sam S Chang; Victor E Reuter; Warren D W Heston; PB Gaudin
Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
Urology 2001;57(6):1179-83.
2001: F Watt; A Martorana; Diana E Brookes; T Ho; Elizabeth A Kingsley; Denise S O'Keefe; Pamela J Russell; Warren D W Heston; Peter Molloy
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.
Genomics 2001;73(3):243-54.
2001: P J Cozzi; Sandeep Malhotra; Priscilla F McAuliffe; David A Kooby; Howard Federoff; B Huryk; P Johnson; Peter T Scardino; Warren D W Heston; Yuman Fong
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(7):1306-8.
2001: Sam S Chang; Victor E Reuter; Warren D W Heston; PB Gaudin
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.
Urology 2001;57(4):801-5.
2001: Dean J Bacich; John Pinto; W P Tong; Warren D W Heston
Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
Mammalian genome : official journal of the International Mammalian Genome Society 2001;12(2):117-23.
2001: J Tasch; M Gong; Michel Sadelain; Warren D W Heston
A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?
Critical reviews in immunology 2001;21(1-3):249-61.
2000: John Pinto; C Qiao; J Xing; B P Suffoletto; K B Schubert; Richard S Rivlin; RF Huryk; Dean J Bacich; Warren D W Heston
Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine.
The Prostate 2000;45(4):304-14.
2000: Denise S O'Keefe; A Uchida; Dean J Bacich; F B Watt; A Martorana; Peter Molloy; Warren D W Heston
Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
The Prostate 2000;45(2):149-57.
2000: William Larchian; Y Horiguchi; S K Nair; William R Fair; Warren D W Heston; Eli Gilboa
Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2913-20.
2000: Y Horiguchi; William Larchian; R Kaplinsky; William R Fair; Warren D W Heston
Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
Gene therapy 2000;7(10):844-51.
2000: Sam S Chang; PB Gaudin; Victor E Reuter; Warren D W Heston
Prostate-specific membrane antigen: present and future applications.
Urology 2000;55(5):622-9.
2000: R Simak; Paola Capodieci; D W Cohen; William R Fair; Howard I Scher; Jonathan Melamed; Marija Drobnjak; Warren D W Heston; U Stix; G Steiner; Carlos Cordon-Cardo
Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Histology and histopathology 2000;15(2):365-74.
2000: W Kevin Kelly; Iman Osman; Victor E Reuter; Tracy Curley; Warren D W Heston; David M Nanus; Howard I Scher
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):838-46.
2000: Sam S Chang; Victor E Reuter; Warren D W Heston; Brian Hutchinson; L S Grauer; PB Gaudin
Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
Cancer 2000;88(2):407-15.
2000: Michael C Gong; Sam S Chang; F Watt; Denise S O'Keefe; Dean J Bacich; A Uchida; Neil H Bander; Victor E Reuter; PB Gaudin; Peter Molloy; M Sadelian; Warren D W Heston
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy.
Molecular urology 2000;4(3):217-22;discussion 223.
1999: Mark Garzotto; Adriana Haimovitz-Friedman; WC Liao; M White-Jones; RF Huryk; Warren D W Heston; Carlos Cardon-Cardo; Richard Kolesnick; Zvi Fuks
Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase.
Cancer research 1999;59(20):5194-201.
1999: Sam S Chang; Denise S O'Keefe; Dean J Bacich; Victor E Reuter; Warren D W Heston; PB Gaudin
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2674-81.
1999: Sam S Chang; Neil H Bander; Warren D W Heston
Monoclonal antibodies: will they become an integral part of the evaluation and treatment of prostate cancer--focus on prostate-specific membrane antigen?
Current opinion in urology 1999;9(5):391-5.
1999: P J Cozzi; Dean F Bajorin; William Tong; H Nguyen; J Scott; Warren D W Heston; Guido Dalbagni
Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2629-37.
1999: Sam S Chang; Victor E Reuter; Warren D W Heston; Neil H Bander; L S Grauer; PB Gaudin
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Cancer research 1999;59(13):3192-8.
1999: Michael C Gong; Jean-Baptiste Latouche; A Krause; Warren D W Heston; Neil H Bander; Michel Sadelain
Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.
Neoplasia (New York, N.Y.) 1999;1(2):123-7.
1999: N Fleshner; William R Fair; RF Huryk; Warren D W Heston
Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice.
The Journal of urology 1999;161(5):1651-4.
1999: Michael C Gong; Sam S Chang; Michel Sadelain; Neil H Bander; Warren D W Heston
Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers.
Cancer metastasis reviews 1999;18(4):483-90.
1998: Denise S O'Keefe; S L Su; Dean J Bacich; Y Horiguchi; Y Luo; CT Powell; Dorethea Zandvliet; Pamela J Russell; Peter Molloy; Norma J Nowak; TB Shows; C Mullins; R A Vonder Haar; William R Fair; Warren D W Heston
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.
Biochimica et biophysica acta 1998;1443(1-2):113-27.
1997: William R Fair; NE Fleshner; Warren D W Heston
Cancer of the prostate: a nutritional disease?
Urology 1997;50(6):840-8.
1997: Mark Garzotto; RF Huryk; William R Fair; Warren D W Heston
Prostatic tumor implantation in the nude mouse via a perineal approach.
The Prostate 1997;33(1):60-3.
1997: John Pinto; C Qiao; J Xing; Richard S Rivlin; M L Protomastro; M L Weissler; Y Tao; Howard T Thaler; Warren D W Heston
Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture.
The American journal of clinical nutrition 1997;66(2):398-405.
1997: William R Fair; R S Israeli; Warren D W Heston
Prostate-specific membrane antigen.
The Prostate 1997;32(2):140-8.
1997: S L Su; Warren D W Heston; Michael Perrotti; MS Cookson; N Stroumbakis; R Huyrk; E Edwards; B Brander; J Coke; SM Soloway; A Lewis; William R Fair; M Perroti
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction.
Urology 1997;49(3A Suppl):95-101.
1997: William R Fair; MS Cookson; N Stroumbakis; D Cohen; Armen G Aprikian; Y Wang; Paul Russo; SM Soloway; Pramod C Sogani; Joel Sheinfeld; Harry W Herr; G Dalgabni; Colin B Begg; Warren D W Heston; Victor E Reuter
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
Urology 1997;49(3A Suppl):46-55.
1997: Warren D W Heston
Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
Urology 1997;49(3A Suppl):104-12.
1997: DA Silver; I Pellicer; William R Fair; Warren D W Heston; Carlos Cordon-Cardo
Prostate-specific membrane antigen expression in normal and malignant human tissues.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):81-5.
1996: John Pinto; B P Suffoletto; T M Berzin; C H Qiao; S Lin; William P Tong; F May; B Mukherjee; Warren D W Heston
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(9):1445-51.
1996: Warren D W Heston
[Significance of prostate-specific membrane antigen (PSMA). A neurocarboxypeptidase and membrane folate hydrolase].
Der Urologe. Ausg. A 1996;35(5):400-7.
1996: CT Powell; N J Brittis; D Stec; H Hug; Warren D W Heston; W R Fair
Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(4):419-28.
1995: Carrie W Rinker-Schaeffer; Anita L Hawkins; S L Su; R S Israeli; Constance A Griffin; John T Isaacs; Warren D W Heston
Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.
Genomics 1995;30(1):105-8.
1995: S L Su; I P Huang; W R Fair; CT Powell; Warren D W Heston
Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
Cancer research 1995;55(7):1441-3.
1995: R S Israeli; W H Miller; S L Su; D S Samadi; CT Powell; Warren D W Heston; Gilbert J Wise; W R Fair
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
The Journal of urology 1995;153(3 Pt 1):573-7.
1995: S Machele Donat; CT Powell; R S Israeli; W R Fair; Warren D W Heston
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
Journal of the National Cancer Institute 1995;87(1):41-6.
1994: S Saito; R Bannerji; B Gansbacher; Felicia M Rosenthal; P Romanenko; Warren D W Heston; W R Fair; Eli Gilboa
Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.
Cancer research 1994;54(13):3516-20.
1994: Zhen Su; Warren D W Heston; Eli Gilboa; W R Fair
An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer.
The Prostate 1994;24(6):291-8.
1994: Paul Russo; J A Warner; RF Huryk; G Perez; Warren D W Heston
TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
The Prostate 1994;24(5):237-43.
1994: Zhen Su; Felicia M Rosenthal; R Bannerji; Warren D W Heston; W R Fair; B Gansbacher; Eli Gilboa
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
Cancer research 1994;54(7):1760-5.
1994: R S Israeli; CT Powell; J G Corr; W R Fair; Warren D W Heston
Expression of the prostate-specific membrane antigen.
Cancer research 1994;54(7):1807-11.
1994: CT Powell; W R Fair; Warren D W Heston
Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(2):143-9.
1993: J Connor; R Bannerji; S Saito; Warren D W Heston; W Fair; Eli Gilboa
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
The Journal of experimental medicine 1993;177(4):1127-34.
1993: K M Manchester; Warren D W Heston; David B Donner
Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells.
The Biochemical journal 1993;290 ( Pt 1)():185-90.
1993: R S Israeli; CT Powell; W R Fair; Warren D W Heston
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
Cancer research 1993;53(2):227-30.
1991: Warren D W Heston
Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer.
Cancer surveys 1991;11():217-38.
1989: Jack H Mydlo; J Michaeli; Carlos Cordon-Cardo; A S Goldenberg; Warren D W Heston; W R Fair
Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue.
Cancer research 1989;49(12):3407-11.
1989: B Omarbasha; W R Fair; Warren D W Heston
Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma.
Cancer research 1989;49(11):3045-9.
1989: Vincent Laudone; T R Morgan; RF Huryk; Warren D W Heston; W R Fair
Cytotoxicity of high energy shock waves: methodologic considerations.
The Journal of urology 1989;141(4):965-8.
1988: Jack H Mydlo; Warren D W Heston; W R Fair
Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney.
The Journal of urology 1988;140(6):1575-9.
1988: Warren D W Heston; M Charles
Calmodulin antagonist inhibition of polyamine transport in prostatic cancer cells in vitro.
Biochemical pharmacology 1988;37(13):2511-4.
1988: Harry W Herr; J L Huffman; RF Huryk; Warren D W Heston; M R Melamed; W F Whitmore
Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.
Cancer research 1988;48(8):2061-3.
1988: Jack H Mydlo; M A Bulbul; Victoria M Richon; Warren D W Heston; W R Fair
Heparin-binding growth factor isolated from human prostatic extracts.
The Prostate 1988;12(4):343-55.
1988: T R Morgan; Vincent Laudone; Warren D W Heston; L Zeitz; W R Fair
Free radical production by high energy shock waves--comparison with ionizing irradiation.
The Journal of urology 1988;139(1):186-9.
1988: C Yang; Warren D W Heston; S Gulati; W R Fair
The effect of high energy shock waves (HESW) on human bone marrow.
Urological research 1988;16(6):427-9.
1988: Jack H Mydlo; J Michaeli; Warren D W Heston; W R Fair
Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma.
The Prostate 1988;13(3):241-7.
1987: Paul Russo; G Liguori; Warren D W Heston; RF Huryk; C R Yang; W R Fair; W F Whitmore; Harry W Herr
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
Cancer research 1987;47(22):5967-70.
1987: Paul Russo; C Mies; RF Huryk; Warren D W Heston; W R Fair
Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves.
The Journal of urology 1987;137(2):338-41.
1987: Warren D W Heston; M A Bulbul; W R Fair
Mitogenic activity of prostatic extracts.
Progress in clinical and biological research 1987;239():235-8.
1986: Paul Russo; R A Stephenson; C Mies; RF Huryk; Warren D W Heston; M R Melamed; W R Fair
High energy shock waves suppress tumor growth in vitro and in vivo.
The Journal of urology 1986;135(3):626-8.